Julie Vose

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Phenomena

Recurrence

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Fenske Timothy S; Hari Parameswaran N; Carreras Jeanette; Zhang Mei-Jie; Kamble Rammurti T; Bolwell Brian J; Cairo Mitchell S; Champlin Richard E; Chen Yi-Bin; Freytes César O; Gale Robert Peter; Hale Gregory A; Ilhan Osman; Khoury H Jean; Lister John; Maharaj Dipnarine; Marks David I; Munker Reinhold; Pecora Andrew L; Rowlings Philip A; Shea Thomas C; Stiff Patrick; Wiernik Peter H; Winter Jane N; Rizzo J Douglas; van Besien Koen; Lazarus Hillard M; Vose Julie M
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma.
Witzig Thomas E; Wiernik Peter H; Moore Timothy; Reeder Craig; Cole Craig; Justice Glen; Kaplan Henry; Voralia Michael; Pietronigro Dennis; Takeshita Kenichi; Ervin-Haynes Annette; Zeldis Jerome B; Vose Julie M
Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's Lymphoma.
Anderson Kenneth C; Alsina Melissa; Bensinger William; Biermann J Sybil; Chanan-Khan Asher; Cohen Adam D; Devine Steven; Djulbegovic Benjamin; Gasparetto Cristina; Huff Carol Ann; Jagasia Madan; Medeiros Bruno C; Meredith Ruby; Raje Noopur; Schriber Jeffrey; Singhal Seema; Somlo George; Stockerl-Goldstein Keith; Tricot Guido; Vose Julie M; Weber Donna; Yahalom Joachim; Yunus Furhan
NCCN Clinical Practice Guidelines in Oncology: Multiple Myeloma.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Julie Vose (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Fenske Timothy S; Hari Parameswaran N; Carreras Jeanette; Zhang Mei-Jie; Kamble Rammurti T; Bolwell Brian J; Cairo Mitchell S; Champlin Richard E; Chen Yi-Bin; Freytes César O; Gale Robert Peter; Hale Gregory A; Ilhan Osman; Khoury H Jean; Lister John; Maharaj Dipnarine; Marks David I; Munker Reinhold; Pecora Andrew L; Rowlings Philip A; Shea Thomas C; Stiff Patrick; Wiernik Peter H; Winter Jane N; Rizzo J Douglas; van Besien Koen; Lazarus Hillard M; Vose Julie M
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(11):1455-64.
2009: Witzig Thomas E; Wiernik Peter H; Moore Timothy; Reeder Craig; Cole Craig; Justice Glen; Kaplan Henry; Voralia Michael; Pietronigro Dennis; Takeshita Kenichi; Ervin-Haynes Annette; Zeldis Jerome B; Vose Julie M
Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's Lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(32):5404-9.
2009: Anderson Kenneth C; Alsina Melissa; Bensinger William; Biermann J Sybil; Chanan-Khan Asher; Cohen Adam D; Devine Steven; Djulbegovic Benjamin; Gasparetto Cristina; Huff Carol Ann; Jagasia Madan; Medeiros Bruno C; Meredith Ruby; Raje Noopur; Schriber Jeffrey; Singhal Seema; Somlo George; Stockerl-Goldstein Keith; Tricot Guido; Vose Julie M; Weber Donna; Yahalom Joachim; Yunus Furhan
NCCN Clinical Practice Guidelines in Oncology: Multiple Myeloma.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(9):908-42.
2009: Choi William W L; Weisenburger Dennis D; Greiner Timothy C; Piris Miguel A; Banham Alison H; Delabie Jan; Braziel Rita M; Geng Huimin; Iqbal Javeed; Lenz Georg; Vose Julie M; Hans Christine P; Fu Kai; Smith Lynette M; Li Min; Liu Zhongfeng; Gascoyne Randy D; Rosenwald Andreas; Ott German; Rimsza Lisa M; Campo Elias; Jaffe Elaine S; Jaye David L; Staudt Louis M; Chan Wing C
A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(17):5494-502.
2009: van Besien Koen; Carreras Jeanette; Bierman Philip J; Logan Brent R; Molina Arturo; King Roberta; Nelson Gene; Fay Joseph W; Champlin Richard E; Lazarus Hillard M; Vose Julie M; Hari Parameswaran N
Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(5):554-63.
2009: Habermann Thomas M; Lossos Izidore S; Justice Glen; Vose Julie M; Wiernik Peter H; McBride Kyle; Wride Kenton; Ervin-Haynes Annette; Takeshita Kenichi; Pietronigro Dennis; Zeldis Jerome B; Tuscano Joseph M
Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma.
British journal of haematology 2009;145(3):344-9.
2009: Friedberg Jonathan W; Taylor Michael D; Cerhan James R; Flowers Christopher R; Dillon Hildy; Farber Charles M; Rogers Eric S; Hainsworth John D; Wong Elaine K; Vose Julie M; Zelenetz Andrew D; Link Brian K
Follicular lymphoma in the United States: first report of the national LymphoCare study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(8):1202-8.
2009: Devetten Marcel P; Hari Parameswaran N; Carreras Jeanette; Logan Brent R; van Besien Koen; Bredeson Christopher N; Freytes César O; Gale Robert Peter; Gibson John; Giralt Sergio A; Goldstein Steven C; Gupta Vikas; Marks David I; Maziarz Richard T; Vose Julie M; Lazarus Hillard M; Anderlini Paolo
Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(1):109-17.
2008: Lazarus Hillard M; Carreras Jeanette; Boudreau Christian; Loberiza Fausto R; Armitage James O; Bolwell Brian J; Freytes César O; Gale Robert Peter; Gibson John; Hale Gregory A; Inwards David J; LeMaistre Charles F; Maharaj Dipnarine; Marks David I; Miller Alan M; Pavlovsky Santiago; Schouten Harry C; van Besien Koen; Vose Julie M; Bitran Jacob D; Khouri Issa F; McCarthy Philip L; Yu Hongmei; Rowlings Philip; Serna Derek S; Horowitz Mary M; Rizzo J Douglas;
Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(12):1323-33.
2008: Aldoss Ibrahim T; Weisenburger Dennis D; Fu Kai; Chan Wing C; Vose Julie M; Bierman Philip J; Bociek R Gregory; Armitage James O
Adult Burkitt lymphoma: advances in diagnosis and treatment.
Oncology (Williston Park, N.Y.) 2008;22(13):1508-17.
2008: Vose Julie M
Peripheral T-cell non-Hodgkin's lymphoma.
Hematology/oncology clinics of North America 2008;22(5):997-1005, x.
2008: Fu Kai; Weisenburger Dennis D; Choi William W L; Perry Kyle D; Smith Lynette M; Shi Xinlan; Hans Christine P; Greiner Timothy C; Bierman Philip J; Bociek R Gregory; Armitage James O; Chan Wing C; Vose Julie M
Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(28):4587-94.
2008: Wiernik Peter H; Lossos Izidore S; Tuscano Joseph M; Justice Glen; Vose Julie M; Cole Craig E; Lam Wendy; McBride Kyle; Wride Kenton; Pietronigro Dennis; Takeshita Kenichi; Ervin-Haynes Annette; Zeldis Jerome B; Habermann Thomas M
Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(30):4952-7.
2008: Young Ken H; Leroy Karen; Møller Michael B; Colleoni Gisele W B; Sánchez-Beato Margarita; Kerbauy Fábio R; Haioun Corinne; Eickhoff Jens C; Young Allen H; Gaulard Philippe; Piris Miguel A; Oberley Terry D; Rehrauer William M; Kahl Brad S; Malter James S; Campo Elias; Delabie Jan; Gascoyne Randy D; Rosenwald Andreas; Rimsza Lisa; Huang James; Braziel Rita M; Jaffe Elaine S; Wilson Wyndham H; Staudt Louis M; Vose Julie M; Chan Wing C; Weisenburger Dennis D; Greiner Timothy C
Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.
Blood 2008;112(8):3088-98.
2008: Smith Sonali M; van Besien Koen; Carreras Jeanette; Bashey Asad; Cairo Mitchell S; Freytes Cesar O; Gale Robert Peter; Hale Gregory A; Hayes-Lattin Brandon; Holmberg Leona A; Keating Armand; Maziarz Richard T; McCarthy Philip L; Navarro Willis H; Pavlovsky Santiago; Schouten Harry C; Seftel Matthew; Wiernik Peter H; Vose Julie M; Lazarus Hillard M; Hari Parameswaran
Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(8):904-12.
2008: Leonard John P; Gregory Stephanie A; Maloney David G; Vose Julie M; Younes Anas; Zelenetz Andrew D
Optimizing the treatment of patients with rituximab-pretreated recurrent indolent non-Hodgkin lymphoma.
Clinical advances in hematology & oncology : H&O 2008;6(6):437-45.
2008: Hegde Ganapati V; Munger Corey M; Emanuel Katy; Joshi Avadhut D; Greiner Timothy C; Weisenburger Dennis D; Vose Julie M; Joshi Shantaram S
Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma.
Molecular cancer therapeutics 2008;7(6):1450-60.
2008: McLaughlin Peter; Vose Julie M
R-DHAP: a good small step, but not the journey's end.
Leukemia & lymphoma 2008;49(6):1019-21.
2008: Savage Kerry J; Harris Nancy Lee; Vose Julie M; Ullrich Fred; Jaffe Elaine S; Connors Joseph M; Rimsza Lisa; Pileri Stefano A; Chhanabhai Mukesh; Gascoyne Randy D; Armitage James O; Weisenburger Dennis D;
ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.
Blood 2008;111(12):5496-504.
2008: Zelenetz Andrew D; Advani Ranjana H; Byrd John C; Czuczman Myron S; Damon Lloyd E; Duvic Madeleine; Fayad Luis; Forero Andres; Glenn Martha J; Gockerman Jon P; Gordon Leo I; Harris Nancy Lee; Hoppe Richard T; Horwitz Steven M; Kaminski Mark S; Kim Youn H; Lacasce Ann S; Nademanee Auyporn; Olsen Elise A; Porcu Pierluigi; Press Oliver; Prosnitz Leonard; Smith Mitchell R; Sotomayor Eduardo M; Vose Julie M; Yahalom Joachim; Yunus Furhan;
Non-Hodgkin's lymphomas.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(4):356-421.
2008: Hari Parameswaran; Carreras Jeanette; Zhang Mei-Jie; Gale Robert Peter; Bolwell Brian J; Bredeson Christopher N; Burns Linda J; Cairo Mitchell S; Freytes César O; Goldstein Steven C; Hale Gregory A; Inwards David J; Lemaistre Charles F; Maharaj Dipnarine; Marks David I; Schouten Harry C; Slavin Shimon; Vose Julie M; Lazarus Hillard M; van Besien Koen
Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(2):236-45.
2008: Vose Julie M; Bierman Philip J; Loberiza Fausto R; Lynch James C; Bociek Gregory R; Weisenburger Dennis D; Armitage James O
Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(1):36-42.
2007: Vose Julie M
Current status of rituximab maintenance therapy.
Clinical advances in hematology & oncology : H&O 2007;5(12):968-9,1006.
2007: Ganti Apar Kishor; Lee Stephanie J; Vose Julie M; Devetten Marcel P; Bociek R Gregory; Armitage James O; Bierman Philip J; Maness Lori J; Reed Elizabeth C; Loberiza Fausto R
Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(35):5643-8.
2007: Rao Keshav; Darrington Deborah L; Schumacher Joseph J; Devetten Marcel; Vose Julie M; Loberiza Fausto R
Disparity in survival outcome after hematopoietic stem cell transplantation for hematologic malignancies according to area of primary residence.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(12):1508-14.
2007: Iqbal J; Greiner T C; Patel K; Dave B J; Smith L; Ji J; Wright G; Sanger W G; Pickering D L; Jain S; Horsman D E; Shen Y; Fu K; Weisenburger D D; Hans C P; Campo E; Gascoyne R D; Rosenwald A; Jaffe E S; Delabie J; Rimsza L; Ott G; Müller-Hermelink H K; Connors J M; Vose J M; McKeithan T; Staudt L M; Chan W C;
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(11):2332-43.
2007: Joshi Avadhut D; Hegde Ganapati V; Dickinson John D; Mittal Amit K; Lynch James C; Eudy James D; Armitage James O; Bierman Philip J; Bociek R Gregory; Devetten Marcel P; Vose Julie M; Joshi Shantaram S
ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 1):5295-304.
2007: Singh Rakesh K; Varney Michelle L; Leutzinger Cheryl; Vose Julie M; Bierman Philip J; Buyukberber Suleyman; Ino Kazuhiko; Loh Kevin; Nichols Craig; Inwards David; Rifkin Robert; Talmadge James E
Immune reconstitution after autologous hematopoietic transplantation with Lin-, CD34+, Thy-1lo selected or intact stem cell products.
International immunopharmacology 2007;7(8):1033-43.
2007: Wiestner Adrian; Tehrani Mahsa; Chiorazzi Michael; Wright George; Gibellini Federica; Nakayama Kazutaka; Liu Hui; Rosenwald Andreas; Muller-Hermelink H Konrad; Ott German; Chan Wing C; Greiner Timothy C; Weisenburger Dennis D; Vose Julie; Armitage James O; Gascoyne Randy D; Connors Joseph M; Campo Elias; Montserrat Emilio; Bosch Francesc; Smeland Erlend B; Kvaloy Stein; Holte Harald; Delabie Jan; Fisher Richard I; Grogan Thomas M; Miller Thomas P; Wilson Wyndham H; Jaffe Elaine S; Staudt Louis M
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.
Blood 2007;109(11):4599-606.
2007: Robertson Michael J; Kahl Brad S; Vose Julie M; de Vos Sven; Laughlin Mary; Flynn Patrick J; Rowland Kendrith; Cruz Jose C; Goldberg Stuart L; Musib Luna; Darstein Christelle; Enas Nathan; Kutok Jeffery L; Aster Jon C; Neuberg Donna; Savage Kerry J; LaCasce Ann; Thornton Donald; Slapak Christopher A; Shipp Margaret A
Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(13):1741-6.
2007: Vose Julie M; Bierman Philip J; Loberiza Fausto R; Bociek Robert G; Matso Daniel; Armitage James O
Phase I trial of (90)Y-ibritumomab tiuxetan in patients with relapsed B-cell non-Hodgkin's lymphoma following high-dose chemotherapy and autologous stem cell transplantation.
Leukemia & lymphoma 2007;48(4):683-90.
2007: Ganti Apar Kishor; Vose Julie M; Haire William D
Hematopoietic stem cell transplantation for Hodgkin's disease in a patient with dysfibrinogenemia and thrombosis.
Journal of thrombosis and thrombolysis 2007;23(2):155-8.
2007: Anderson Kenneth C; Alsina Melissa; Bensinger William; Biermann J Sybil; Chanan-Khan Asher; Comenzo Raymond L; De Castro Carlos M; Djulbegovic Benjamin; Farag Sherif; Huff Carol Ann; Meredith Ruby; Schriber Jeffrey; Shrieve Dennis; Singhal Seema; Smith Mitchell R; Stockerl-Goldstein Keith; Vose Julie M; Weber Donna; Yahalom Joachim; Yunus Furhan;
Multiple myeloma. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(2):118-47.
2007: Cheson Bruce D; Pfistner Beate; Juweid Malik E; Gascoyne Randy D; Specht Lena; Horning Sandra J; Coiffier Bertrand; Fisher Richard I; Hagenbeek Anton; Zucca Emanuele; Rosen Steven T; Stroobants Sigrid; Lister T Andrew; Hoppe Richard T; Dreyling Martin; Tobinai Kensei; Vose Julie M; Connors Joseph M; Federico Massimo; Diehl Volker;
Revised response criteria for malignant lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(5):579-86.
2007: Albitar Maher; Vose Julie M; Johnson Marcella M; Do Kim-Ann; Day Amanda; Jilani Iman; Kantarjian Hagop; Keating Michael; O'Brien Susan M; Verstovsek Srdan; Armitage James O; Giles Francis J
Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
Leukemia research 2007;31(2):139-45.
2007: Vose Julie M; Panwalkar Amit; Belanger Robert; Coiffier Bertrand; Baccarani Michele; Gregory Stephanie A; Facon Thierry; Fanin Renato; Caballero Dolores; Ben-Yehuda Dina; Giles Francis
A phase II multicenter study of troxacitabine in relapsed or refractory lymphoproliferative neoplasms or multiple myeloma.
Leukemia & lymphoma 2007;48(1):39-45.
2007: Joshi Avadhut D; Dickinson John D; Hegde Ganapati V; Sanger Warren G; Armitage James O; Bierman Philip J; Bociek Robert G; Devetten Marcel P; Vose Julie M; Joshi Shantaram S
Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion.
Cancer genetics and cytogenetics 2007;172(2):120-6.
2006: Bennett Charles L; Evens Andrew M; Andritsos Leslie A; Balasubramanian Lakshmi; Mai Mark; Fisher Matthew J; Kuzel Timothy M; Angelotta Cara; McKoy June M; Vose Julie M; Bierman Philip J; Kuter David J; Trifilio Steven M; Devine Steven M; Tallman Martin S
Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project.
British journal of haematology 2006;135(5):642-50.
2006: Ashour Abdel-Kader; Petersen Jason L; McIlhaney Mary M; Vose Julie M; Solheim Joyce C
Effect of linkage of transduction domain sequences to a lymphoma idiotype DNA vaccine on vaccine effectiveness.
Hybridoma (2005) 2006;25(5):306-8.
2006: Villanueva Mary Lee H; Vose Julie M
The role of hematopoietic stem cell transplantation in non-Hodgkin lymphoma.
Clinical advances in hematology & oncology : H&O 2006;4(7):521-30.
2006: Munger Corey M; Vose Julie M; Joshi Shantaram S
Dendritic cell-based therapy for mantle cell lymphoma.
International journal of oncology 2006;28(6):1337-43.
2006: Ganti A K; Weisenburger D D; Smith L M; Hans C P; Bociek R G; Bierman P J; Vose J M; Armitage J O
Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(6):920-7.
2006: Vose Julie M
Personalized immunotherapy for the treatment of non-Hodgkin's lymphoma: a promising approach.
Hematological oncology 2006;24(2):47-55.
2006: Navarro Willis H; Loberiza Fausto R; Bajorunaite Ruta; van Besien Koen; Vose Julie M; Lazarus Hillard M; Rizzo J Douglas
Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(5):541-51.
2006: Fisher Richard I; Coiffier Bertrand; Vose Julie M
Advances in the treatment of hematologic malignancies. Part 1 of a 3-part series: Aggressive lymphomas.
Clinical advances in hematology & oncology : H&O 2006;4(4):suppl 1, 4-9; discussion suppl 10; quiz 2 p following suppl 10.
2006: Armitage James O; Bierman Philip J; Bociek R Gregory; Vose Julie M
Lymphoma 2006: classification and treatment.
Oncology (Williston Park, N.Y.) 2006;20(3):231-9; discussion 242, 244, 249.
2006: Zelenetz Andrew D; Advani Ranjana H; Buadi Francis; Cabanillas Fernando; Caligiuri Michael A; Czuczman Myron S; Damon Lloyd E; Fayad Luis; Flinn Ian W; Forero Andres; Glenn Martha J; Gockerman Jon P; Gordon Leo I; Harris Nancy Lee; Hoppe Richard T; Kaminski Mark S; Lacasce Ann S; Nademanee Auyporn; Porcu Pierluigi; Press Oliver; Prosnitz Leonard; Smith Mitchell R; Sotomayor Eduardo M; Vose Julie M; Yahalom Joachim;
Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(3):258-310.
2006: Greiner Timothy C; Dasgupta Chiranjib; Ho Vincent V; Weisenburger Dennis D; Smith Lynette M; Lynch James C; Vose Julie M; Fu Kai; Armitage James O; Braziel Rita M; Campo Elias; Delabie Jan; Gascoyne Randy D; Jaffe Elaine S; Muller-Hermelink Hans K; Ott German; Rosenwald Andreas; Staudt Louis M; Im Michael Y; Karaman Mazen W; Pike Brian L; Chan Wing C; Hacia Joseph G
Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(7):2352-7.
2006: Iqbal Javeed; Neppalli Vishala T; Wright George; Dave Bhavana J; Horsman Douglas E; Rosenwald Andreas; Lynch James; Hans Christine P; Weisenburger Dennis D; Greiner Timothy C; Gascoyne Randy D; Campo Elias; Ott German; Müller-Hermelink H Konrad; Delabie Jan; Jaffe Elaine S; Grogan Thomas M; Connors Joseph M; Vose Julie M; Armitage James O; Staudt Louis M; Chan Wing C
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(6):961-8.
2005: Vose Julie
Personalized immunotherapy for the treatment of non-Hodgkin lymphoma: a promising approach.
Clinical advances in hematology & oncology : H&O 2005;3(12):923-32.
2005: Vose J M; Link B K; Grossbard M L; Czuczman M; Grillo-Lopez A; Fisher R I
Long-term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma.
Leukemia & lymphoma 2005;46(11):1569-73.
2005: Fisher Richard I; Kaminski Mark S; Wahl Richard L; Knox Susan J; Zelenetz Andrew D; Vose Julie M; Leonard John P; Kroll Stewart; Goldsmith Stanley J; Coleman Morton
Tositumomab and iodine-131 tositumomab produces durable complete remissions in a subset of heavily pretreated patients with low-grade and transformed non-Hodgkin's lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7565-73.
2005: Hans Christine P; Weisenburger Dennis D; Greiner Timothy C; Chan Wing C; Aoun Patricia; Cochran Gregory T; Pan Zenggang; Smith Lynette M; Lynch James C; Bociek Robert Gregory; Bierman Philip J; Vose Julie M; Armitage James O
Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(10):1377-84.
2005: Balducci Lodovico; Cohen Harvey Jay; Engstrom Paul F; Ettinger David S; Halter Jeffrey; Gordon Leo I; Kiel Krystyna; Kneier Andrew; Lim Dean; Petersdorf Stephen H; Rosenthal Ronnie; Silliman Rebecca; Vose Julie M; Walker Michael J; Zachariah Babu;
Senior adult oncology clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(4):572-90.
2005: Czuczman Myron S; Thall Aron; Witzig Thomas E; Vose Julie M; Younes Anas; Emmanouilides Christos; Miller Thomas P; Moore Joseph O; Leonard John P; Gordon Leo I; Sweetenham John; Alkuzweny Baha; Finucane Deborah M; Leigh Bryan R
Phase I/II study of galiximab, an anti-CD80 antibody, for relapsed or refractory follicular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(19):4390-8.
2005: Juweid Malik E; Wiseman Gregory A; Vose Julie M; Ritchie Justine M; Menda Yusuf; Wooldridge James E; Mottaghy Felix M; Rohren Eric M; Blumstein Norbert M; Stolpen Alan; Link Brian K; Reske Sven N; Graham Michael M; Cheson Bruce D
Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(21):4652-61.
2005: Bennett John M; Kaminski Mark S; Leonard John P; Vose Julie M; Zelenetz Andrew D; Knox Susan J; Horning Sandra; Press Oliver W; Radford John A; Kroll Stewart M; Capizzi Robert L
Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab.
Blood 2005;105(12):4576-82.
2005: Pavletic Steven Z; Smith Lynette M; Bishop Michael R; Lynch James C; Tarantolo Stefano R; Vose Julie M; Bierman Philip J; Hadi Abdul; Armitage James O; Kessinger Anne
Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
American journal of hematology 2005;78(4):265-74.
2005: Ganti A K; Bierman P J; Lynch J C; Bociek R G; Vose J M; Armitage J O
Hematopoietic stem cell transplantation in mantle cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(4):618-24.
2005: Ganti Apar Kishor; Bociek R Gregory; Bierman Philip J; Enke Charles A; Vose Julie M; Armitage James O
Follicular lymphoma: expanding therapeutic options.
Oncology (Williston Park, N.Y.) 2005;19(2):213-28; discussion 228, 233-6, 239.
2005: Vose Julie M; Bierman Philip J; Enke Charles; Hankins Jordan; Bociek Gregory; Lynch James C; Armitage James O
Phase I trial of iodine-131 tositumomab with high-dose chemotherapy and autologous stem-cell transplantation for relapsed non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):461-7.
2005: Vose Julie M; Neumann M; Harris Mildred E
Update on lymphoma management: diffuse large B-cell NHL.
Hematology (Amsterdam, Netherlands) 2005;10 Suppl 1():10-4.
2004: Devetten Marcel P; Vose Julie M
Graft-versus-host disease: how to translate new insights into new therapeutic strategies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(12):815-25.
2004: Freytes César O; Loberiza Fausto R; Rizzo J Douglas; Bashey Asad; Bredeson Christopher N; Cairo Mitchell S; Gale Robert Peter; Horowitz Mary M; Klumpp Thomas R; Martino Rodrigo; McCarthy Philip L; Molina Arturo; Pavlovsky Santiago; Pecora Andrew L; Serna Derek S; Tsai Tsuong; Zhang Mei-Jie; Vose Julie M; Lazarus Hillard M; van Besien Koen;
Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry.
Blood 2004;104(12):3797-803.
2004: Nola Marin; Pavletic Steven Z; Weisenburger Dennis D; Smith Lynette M; Bast Martin A; Vose Julie M; Armitage James O
Prognostic factors influencing survival in patients with B-cell small lymphocytic lymphoma.
American journal of hematology 2004;77(1):31-5.
2004: Huang James Z; Weisenburger Dennis D; Vose Julie M; Greiner Timothy C; Aoun Patricia; Chan Wing C; Lynch James C; Bierman Philip J; Armitage James O
Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group.
Leukemia & lymphoma 2004;45(8):1551-7.
2004: Iqbal Javeed; Sanger Warren G; Horsman Douglas E; Rosenwald Andreas; Pickering Diane L; Dave Bhavana; Dave Sandeep; Xiao Li; Cao Kajia; Zhu Quiming; Sherman Simon; Hans Christine P; Weisenburger Dennis D; Greiner Timothy C; Gascoyne Randy D; Ott German; Müller-Hermelink H Konrad; Delabie Jan; Braziel Rita M; Jaffe Elaine S; Campo Elias; Lynch James C; Connors Joseph M; Vose Julie M; Armitage James O; Grogan Thomas M; Staudt Louis M; Chan Wing C
BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma.
The American journal of pathology 2004;165(1):159-66.
2004: Forero Andres; Weiden Paul L; Vose Julie M; Knox Susan J; LoBuglio Albert F; Hankins Jordan; Goris Michael L; Picozzi Vincent J; Axworthy Don B; Breitz Hazel B; Sims Robert B; Ghalie Richard G; Shen Sui; Meredith Ruby F
Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma.
Blood 2004;104(1):227-36.
2004: Giles Francis J; Vose Julie M; Do Kim-Anh; Johnson Marcella M; Manshouri Taghi; Bociek Gregory; Bierman Philip J; O'Brien Susan M; Kantarjian Hagop M; Armitage James O; Albitar Maher
Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin's lymphoma or Hodgkin's lymphoma.
Leukemia research 2004;28(6):595-604.
2004: Vose Julie M; Rizzo Douglas J; Tao-Wu Jing; Armitage James O; Bashey Asad; Burns Linda J; Christiansen Neal Paul; Freytes Cesar O; Gale Robert Peter; Gibson John; Giralt Sergio A; Herzig Roger H; Lemaistre Charles F; McCarthy Philip L; Nimer Stephen D; Petersen Finn B; Schenkein David P; Wiernik Peter H; Wiley Joseph M; Loberiza Fausto R; Lazarus Hillard M; van Biesen Koen; Horowitz Mary M
Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(2):116-27.
2004: Vose Julie M
Bexxar: novel radioimmunotherapy for the treatment of low-grade and transformed low-grade non-Hodgkin's lymphoma.
The oncologist 2004;9(2):160-72.
2003: Giles Francis J; Vose Julie M; Do Kim-Anh; Johnson Marcella M; Manshouri Taghi; Bociek Gregory; Bierman Philip J; O'Brien Susan M; Keating Michael J; Kantarjian Hagop M; Armitage James O; Albitar Maher
Circulating CD20 and CD52 in patients with non-Hodgkin's lymphoma or Hodgkin's disease.
British journal of haematology 2003;123(5):850-7.
2003: Huang James Z; Weisenburger Dennis D; Vose Julie M; Greiner Timothy C; Aoun Patricia; Chan Wing C; Lynch James C; Bierman Philip J; Armitage James O;
Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group.
Leukemia & lymphoma 2003;44(11):1903-10.
2003: van Besien Koen; Loberiza Fausto R; Bajorunaite Ruta; Armitage James O; Bashey Asad; Burns Linda J; Freytes Cesar O; Gibson John; Horowitz Mary M; Inwards David J; Marks David I; Martino Rodrigo; Maziarz Richard T; Molina Arturo; Pavlovsky Santiago; Pecora Andrew L; Schouten Harry C; Shea Thomas C; Lazarus Hillard M; Rizzo J Douglas; Vose Julie M
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.
Blood 2003;102(10):3521-9.
2003: Juweid Malik; DeNardo Gerald L; Graham Michael; Vose Julie
Radioimmunotherapy: a novel treatment modality for B-cell non-Hodgkin's lymphoma.
Cancer biotherapy & radiopharmaceuticals 2003;18(5):673-4.
2003: Hahn Theresa; Wolff Steven N; Czuczman Myron; Fisher Richard I; Lazarus Hillard M; McCarthy Philip L; Vose Julie; Warren Lisa; Watt Richard;
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large cell B-cell non-Hodgkin's lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(10):667.
2003: Bierman Philip J; Sweetenham John W; Loberiza Fausto R; Taghipour Goli; Lazarus Hillard M; Rizzo J Douglas; Schmitz Norbert; van Besien Koen; Vose Julie M; Horowitz Mary; Goldstone Anthony;
Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(20):3744-53.
2003: Pavletic Steven Z; Bociek R Gregory; Foran James M; Rubocki Ronald J; Kuszynski Charles A; Wisecarver James L; Hatcher Lori; Lucas David M; Byrd John C; Grever Michael R; Joshi Shantaram S; Hardiman Penny; Smith Lynette M; McGuire Timothy R; Bierman Philip J; Vose Julie M; Armitage James O; Talmadge James E
Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantation.
Transplantation 2003;76(5):877-81.
2003: Hohenstein Maribeth A; Augustine Samuel C; Rutar Frank; Vose Julie M
Establishing an institutional model for the administration of tositumomab and iodine I 131 tositumomab.
Seminars in oncology 2003;30(2 Suppl 4):39-49.
2003: Fang Nicole Y; Greiner Timothy C; Weisenburger Dennis D; Chan Wing C; Vose Julie M; Smith Lynette M; Armitage James O; Mayer R Aeryn; Pike Brian L; Collins Francis S; Hacia Joseph G
Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(9):5372-7.
2003: Levine John E; Harris Richard E; Loberiza Fausto R; Armitage James O; Vose Julie M; Van Besien Koen; Lazarus Hillard M; Horowitz Mary M; Bashey Asad; Bolwell Brian J; Burns Linda J; Cairo Mitchell S; Champlin Richard E; Freytes Cesar O; Gibson John; Goldstein Steve C; Laughlin Mary J; Lister John; Marks David I; Maziarz Richard T; Miller Alan M; Milone Gustavo A; Pavlovsky Santiago; Pecora Amdrew L; Rizzo J Douglas; Schiller Gary; Schouten Harry C; Zhang Mei Jie;
A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma.
Blood 2003;101(7):2476-82.
2003: Vandenberghe Elisabeth; Ruiz de Elvira Carmen; Loberiza Fausto R; Conde E; López-Guillermo A; Gisselbrecht C; Guilhot F; Vose Julie M; van Biesen Koen; Rizzo J Douglas; Weisenburger Dennis D; Isaacson Peter; Horowitz Mary M; Goldstone Anthony H; Lazarus Hillard M; Schmitz Norbert
Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries.
British journal of haematology 2003;120(5):793-800.
2003: Hans Christine P; Weisenburger Dennis D; Vose Julie M; Hock Lynette M; Lynch James C; Aoun Patricia; Greiner Timothy C; Chan Wing C; Bociek Robert G; Bierman Philip J; Armitage James O
A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival.
Blood 2003;101(6):2363-7.
2003: Metayer Catherine; Curtis Rochelle E; Vose Julie; Sobocinski Kathleen A; Horowitz Mary M; Bhatia Smita; Fay Joseph W; Freytes Cesar O; Goldstein Steven C; Herzig Roger H; Keating Armand; Miller Carol B; Nevill Thomas J; Pecora Andrew L; Rizzo J Douglas; Williams Stephanie F; Li Chin-Yang; Travis Lois B; Weisdorf Daniel J
Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.
Blood 2003;101(5):2015-23.
2003: Vose J M; Crump M; Lazarus H; Emmanouilides C; Schenkein D; Moore J; Frankel S; Flinn I; Lovelace W; Hackett J; Liang B C
Randomized, multicenter, open-label study of pegfilgrastim compared with daily filgrastim after chemotherapy for lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(3):514-9.
2003: Joshi S S; Bishop M R; Lynch J C; Tarantolo S R; Abhyankar S; Bierman P J; Vose J M; Geller R B; McGuirk J; Foran J; Bociek R G; Hadi A; Day S D; Armitage J O; Kessinger A; Pavletic Z S
Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.
Cytotherapy 2003;5(6):542-52.
2003: Vose J; Sneller V
Outpatient regimen rituximab plus ifosfamide, carboplatin and etoposide (R-ICE) for relapsed non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14 Suppl 1():i17-20.
2002: Bierman P J; Lynch J C; Bociek R G; Whalen V L; Kessinger A; Vose J M; Armitage J O
The International Prognostic Factors Project score for advanced Hodgkin's disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(9):1370-7.
2002: Vose Julie M; Sharp Graham; Chan Wing C; Nichols Craig; Loh Kevin; Inwards David; Rifkin Robert; Bierman Philip J; Lynch James C; Weisenburger Dennis D; Kessinger Anne; Armitage James O
Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(9):2344-52.
2002: Vose Julie M; Weisenburger Dennis D; Lynch James C; Bierman Philip J; Chan John C; Bast Martin; Aoun Patricia; Bociek Gregory; Greiner Timothy; Armitage James O;
CNOP for diffuse aggressive non-Hodgkin's lymphoma: the Nebraska lymphoma study group experience.
Leukemia & lymphoma 2002;43(4):799-804.
2002: Weekes Colin D; Vose Julie M; Lynch Jim C; Weisenburger Dennis D; Bierman Philip J; Greiner Timothy; Bociek Gregory; Enke Charles; Bast Martin; Chan Wing C; Armitage James O;
Hodgkin's disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(4):1087-93.
2002: Augustine Samuel C; Norenberg Jeffrey P; Colcher David M; Vose Julie M; Gobar Lisa S; Dukat Valorie J; Hohenstein Maribeth A; Rutar Frank J; Jacobson David A; Tempero Margaret A
Combination therapy for non-Hodgkin's lymphoma: an opportunity for pharmaceutical care in a specialty practice.
Journal of the American Pharmaceutical Association (Washington,D.C. : 1996) 2002;42(1):93-100.
2002: Vose Julie M; Chiu Brian C-H; Cheson Bruce D; Dancey Janet; Wright John
Update on epidemiology and therapeutics for non-Hodgkin's lymphoma.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2002;():241-62.
2001: Kaminski M S; Zelenetz A D; Press O W; Saleh M; Leonard J; Fehrenbacher L; Lister T A; Stagg R J; Tidmarsh G F; Kroll S; Wahl R L; Knox S J; Vose J M
Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(19):3918-28.
2001: Sharp J G; Bishop M R; Copple B; Greiner T C; Iversen P L; Jackson J D; Joshi S S; Benner E J; Mann S L; Rao A K; Vose J M
Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cells.
Leukemia & lymphoma 2001;42(3):417-27.
2001: Rutar F J; Augustine S C; Colcher D; Siegel J A; Jacobson D A; Tempero M A; Dukat V J; Hohenstein M A; Gobar L S; Vose J M
Outpatient treatment with (131)I-anti-B1 antibody: radiation exposure to family members.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(6):907-15.
2001: Khorana A; Bunn P; McLaughlin P; Vose J; Stewart C; Czuczman M S
A phase II multicenter study of CAMPATH-1H antibody in previously treated patients with nonbulky non-Hodgkin's lymphoma.
Leukemia & lymphoma 2001;41(1-2):77-87.
2001: Lazarus H M; Loberiza F R; Zhang M J; Armitage J O; Ballen K K; Bashey A; Bolwell B J; Burns L J; Freytes C O; Gale R P; Gibson J; Herzig R H; LeMaistre C F; Marks D; Mason J; Miller A M; Milone G A; Pavlovsky S; Reece D E; Rizzo J D; van Besien K; Vose J M; Horowitz M M
Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
Bone marrow transplantation 2001;27(4):387-96.
2001: Vose J M
Immunotherapy for non-Hodgkin's lymphoma.
Oncology (Williston Park, N.Y.) 2001;15(2):141-7, 151; discussion 152-5.
2001: Vose J M; Zhang M J; Rowlings P A; Lazarus H M; Bolwell B J; Freytes C O; Pavlovsky S; Keating A; Yanes B; van Besien K; Armitage J O; Horowitz M M;
Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):406-13.
2001: Vose J M; Link B K; Grossbard M L; Czuczman M; Grillo-Lopez A; Gilman P; Lowe A; Kunkel L A; Fisher R I
Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):389-97.
2001: Vose J M; Bierman P J; Lynch J C; Atkinson K; Juttner C; Hanania C E; Bociek G; Armitage J O
Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(12):680-7.
2001: Hahn T; Wolff S N; Czuczman M; Fisher R I; Lazarus H M; Vose J; Warren L; Watt R; McCarthy P L;
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin's lymphoma: an evidence-based review.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(6):308-31.
2000: Bishop M R; Tarantolo S R; Geller R B; Lynch J C; Bierman P J; Pavletic Z S; Vose J M; Kruse S; Dix S P; Morris M E; Armitage J O; Kessinger A
A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation.
Blood 2000;96(1):80-5.
2000: Weisenburger D D; Vose J M; Greiner T C; Lynch J C; Chan W C; Bierman P J; Dave B J; Sanger W G; Armitage J O
Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group.
American journal of hematology 2000;64(3):190-6.
2000: Vose J M; Cabanillas F; O'Brien S; Dang N; Drapkin R; Foss F
Infectious complications of pentostatin therapy.
Oncology (Williston Park, N.Y.) 2000;14(6 Suppl 2):41-2.
2000: Vose J M; Colcher D; Gobar L; Bierman P J; Augustine S; Tempero M; Leichner P; Lynch J C; Goldenberg D; Armitage J O
Phase I/II trial of multiple dose 131Iodine-MAb LL2 (CD22) in patients with recurrent non-Hodgkin's lymphoma.
Leukemia & lymphoma 2000;38(1-2):91-101.
2000: Singh R K; Varney M L; Ino K; Vose J M; Bierman P J; Talmadge J E
Immune dysfunction despite high levels of immunoregulatory cytokine gene expression in autologous peripheral blood stem cell transplanted non-Hodgkin's lymphoma patients.
Experimental hematology 2000;28(5):499-507.
2000: Pavletic Z S; Arrowsmith E R; Bierman P J; Goodman S A; Vose J M; Tarantolo S R; Stein R S; Bociek G; Greer J P; Wu C D; Kollath J P; Weisenburger D D; Kessinger A; Wolff S N; Armitage J O; Bishop M R
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia.
Bone marrow transplantation 2000;25(7):717-22.
2000: Vose J M; Wahl R L; Saleh M; Rohatiner A Z; Knox S J; Radford J A; Zelenetz A D; Tidmarsh G F; Stagg R J; Kaminski M S
Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(6):1316-23.
2000: Weisenburger D D; Gascoyne R D; Bierman P J; Shenkier T; Horsman D E; Lynch J C; Chan W C; Greiner T C; Connors J M; Vose J M; Armitage J O; Sanger W G
Clinical significance of the t(14;18) and BCL2 overexpression in follicular large cell lymphoma.
Leukemia & lymphoma 2000;36(5-6):513-23.
2000: Vose J M
Therapeutic uses of MAbs directed against CD20.
Cytotherapy 2000;2(6):455-61.
2000: Vose J M; Bierman P J; Weisenburger D D; Lynch J C; Bociek Y; Chan W C; Greiner T C; Armitage J O
Autologous hematopoietic stem cell transplantation for mantle cell lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(6):640-5.
2000: Nash R A; Kurzrock R; DiPersio J; Vose J; Linker C; Maharaj D; Nademanee A P; Negrin R; Nimer S; Shulman H; Ashby M; Jones D; Appelbaum F R; Champlin R
A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(1):25-34.
1999: Vose J M
Antibody-targeted therapy for low-grade lymphoma.
Seminars in hematology 1999;36(4 Suppl 6):15-20.
1999: Freeman M; Vose J; Bennett C; Anderson J; Kessinger A; Turner K; Pierson J; Bishop M; Bierman P; Armitage J
Costs of care associated with high-dose therapy and autologous transplantation for non-Hodgkin's lymphoma: results from the University of Nebraska Medical Center 1989 to 1995.
Bone marrow transplantation 1999;24(6):679-84.
1999: Tezcan H; Vose J M; Bast M; Bierman P J; Kessinger A; Armitage J O
Limited stage I and II follicular non-Hodgkin's lymphoma: the Nebraska Lymphoma Study Group experience.
Leukemia & lymphoma 1999;34(3-4):273-85.
1999: Gascoyne R D; Aoun P; Wu D; Chhanabhai M; Skinnider B F; Greiner T C; Morris S W; Connors J M; Vose J M; Viswanatha D S; Coldman A; Weisenburger D D
Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma.
Blood 1999;93(11):3913-21.
1999: Cheson B D; Horning S J; Coiffier B; Shipp M A; Fisher R I; Connors J M; Lister T A; Vose J; Grillo-López A; Hagenbeek A; Cabanillas F; Klippensten D; Hiddemann W; Castellino R; Harris N L; Armitage J O; Carter W; Hoppe R; Canellos G P
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(4):1244.
1999: Baker K S; Gordon B G; Gross T G; Abromowitch M A; Lyden E R; Lynch J C; Vose J M; Armitage J O; Coccia P F; Bierman P J
Autologous hematopoietic stem-cell transplantation for relapsed or refractory Hodgkin's disease in children and adolescents.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):825-31.
1999: Abou-Elella A A; Weisenburger D D; Vose J M; Kollath J P; Lynch J C; Bast M A; Bierman P J; Greiner T C; Chan W C; Armitage J O
Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):784-90.
1999: Lazarus H M; Rowlings P A; Zhang M J; Vose J M; Armitage J O; Bierman P J; Gajewski J L; Gale R P; Keating A; Klein J P; Miller C B; Phillips G L; Reece D E; Sobocinski K A; van Besien K; Horowitz M M
Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):534-45.
1999: Ageitos A G; Varney M L; Bierman P J; Vose J M; Warkentin P I; Talmadge J E
Comparison of monocyte-dependent T cell inhibitory activity in GM-CSF vs G-CSF mobilized PSC products.
Bone marrow transplantation 1999;23(1):63-9.
1998: Pavletic Z S; Bierman P J; Vose J M; Bishop M R; Wu C D; Pierson J L; Kollath J P; Weisenburger D D; Kessinger A; Armitage J O
High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(9):1023-6.
1998: Weekes C D; Pirruccello S J; Vose J M; Kuszynski C; Sharp J G
Lymphoma cells associated with bone marrow stromal cells in culture exhibit altered growth and survival.
Leukemia & lymphoma 1998;31(1-2):151-65.
1998: van Besien K; Sobocinski K A; Rowlings P A; Murphy S C; Armitage J O; Bishop M R; Chaekal O K; Gale R P; Klein J P; Lazarus H M; McCarthy P L; Raemaekers J M; Reiffers J; Phillips G L; Schattenberg A V; Verdonck L F; Vose J M; Horowitz M M
Allogeneic bone marrow transplantation for low-grade lymphoma.
Blood 1998;92(5):1832-6.
1998: Vose J M
Current approaches to the management of non-Hodgkin's lymphoma.
Seminars in oncology 1998;25(4):483-91.
1998: Hauke R J; Greiner T C; Smir B N; Vose J M; Tarantolo S R; Bashir R M; Bierman P J
Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases.
Bone marrow transplantation 1998;21(12):1271-4.
1998: Bernstein S H; Nademanee A P; Vose J M; Tricot G; Fay J W; Negrin R S; DiPersio J; Rondon G; Champlin R; Barnett M J; Cornetta K; Herzig G P; Vaughan W; Geils G; Keating A; Messner H; Wolff S N; Miller K B; Linker C; Cairo M; Hellmann S; Ashby M; Stryker S; Nash R A
A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation.
Blood 1998;91(9):3509-17.
1998: Vose J M; Bierman P J; Lynch J C; Weisenburger D D; Kessinger A; Chan W C; Greiner T C; Armitage J O
Effect of follicularity on autologous transplantation for large-cell non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):844-9.
1998: Pavletic Z S; Joshi S S; Pirruccello S J; Tarantolo S R; Kollath J; Reed E C; Bierman P J; Vose J M; Warkentin P I; Gross T G; Nasrati K; Armitage J O; Kessinger A; Bishop M R
Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies.
Bone marrow transplantation 1998;21(1):33-41.
1998: Haire W D; Ruby E I; Stephens L C; Reed E; Tarantolo S R; Pavletic Z S; Bierman P J; Bishop M; Kessinger A; Vose J; Armitage J O
A prospective randomized double-blind trial of antithrombin III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1998;4(3):142-50.
1998: Vose J M
High-dose chemotherapy and hematopoietic stem cell transplantation for relapsed or refractory diffuse large-cell non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9 Suppl 1():S1-3.
1997: Wu G Q; Sharp J G; Wu G; Vose J; Greiner T C; Chan W C
The detection of minimal lymphoma by molecular and combined culture-molecular methods.
British journal of haematology 1997;99(4):873-81.
1997: Vose J M; Pandite A N; Beveridge R A; Geller R B; Schuster M W; Anderson J E; LeMaistre C F; Ahmed T; Granena A; Keating A; Fernandez Ranada J M; Stiff P J; Tabbara I; Longo W; Copelan E A; Nichols C; Smith A; Topolsky D L; Bierman P J; Lebsack M E; Lange M; Garrison L
Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: results of a randomized double-blind trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1617-23.
1997: Pavletic Z S; Bishop M R; Tarantolo S R; Martin-Algarra S; Bierman P J; Vose J M; Reed E C; Gross T G; Kollath J; Nasrati K; Jackson J D; Armitage J O; Kessinger A
Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1608-16.
1997: Bishop M R; Tarantolo S R; Jackson J D; Anderson J R; Schmit-Pokorny K; Zacharias D; Pavletic Z S; Pirruccello S J; Vose J M; Bierman P J; Warkentin P I; Armitage J O; Kessinger A
Allogeneic-blood stem-cell collection following mobilization with low-dose granulocyte colony-stimulating factor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1601-7.
1997: Bierman P J; Vose J M; Anderson J R; Bishop M R; Kessinger A; Armitage J O
High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):445-50.
1997: Talmadge J E; Reed E; Ino K; Kessinger A; Kuszynski C; Heimann D; Varney M; Jackson J; Vose J M; Bierman P J
Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow.
Bone marrow transplantation 1997;19(2):161-72.
1996: Bishop M R; Jackson J D; O'Kane-Murphy B; Schmit-Pokorny K; Vose J M; Bierman P J; Warkentin P I; Armitage J O; Garrison L; Kessinger A
Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(9):2521-6.
1996: Vose J M; Bierman P J; Anderson J R; Harrison K A; Dalrymple G V; Byar K; Kessinger A; Armitage J O
Single-photon emission computed tomography gallium imaging versus computed tomography: predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(9):2473-9.
1996: Vose J M; Bierman P J; Ruby E; Reed E C; Bishop M R; Tarantolo S; Kessinger A; Armitage J O
Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
Bone marrow transplantation 1996;17(6):951-6.
1996: Vose J M
Dose-intensive ifosfamide for the treatment of non-Hodgkin's lymphoma.
Seminars in oncology 1996;23(3 Suppl 6):33-7.
1996: Weisenburger D D; Gordon B G; Vose J M; Bast M A; Chan W C; Greiner T C; Anderson J R; Sanger W G
Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma.
Blood 1996;87(9):3860-8.
1996: Jain B; Floreani A A; Anderson J R; Vose J M; Robbins R A; Rennard S I; Sisson J H
Cardiopulmonary function and autologous bone marrow transplantation: results and predictive value for respiratory failure and mortality. The University of Nebraska Medical Center Bone Marrow Transplantation Pulmonary Study Group.
Bone marrow transplantation 1996;17(4):561-8.
1996: Bierman P J; Vose J M; Langnas A N; Rifkin R M; Hauke R J; Smir B N; Greiner T C
Hodgkin's disease following solid organ transplantation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(3):265-70.
1996: Bierman P J; Anderson J R; Freeman M B; Vose J M; Kessinger A; Bishop M R; Armitage J O
High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(2):151-6.
1996: Gajewski J L; Phillips G L; Sobocinski K A; Armitage J O; Gale R P; Champlin R E; Herzig R H; Hurd D D; Jagannath S; Klein J P; Lazarus H M; McCarthy P L; Pavlovsky S; Peterson F B; Rowlings P A; Russell J A; Silver S M; Vose J M; Wiernik P H; Bortin M M; Horowitz M M
Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):572-8.
1996: Vose J M; Anderson J E; Bierman P J; Appelbaum F R; Anderson J R; Garrison L; Lebsack M E; Armitage J O
Phase I/II trial of PIXY321 to enhance engraftment following autologous bone marrow transplantation for lymphoid malignancy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):520-6.
1996: Vose J M
Classification and clinical course of low-grade non-Hodgkin's lymphomas with overview of therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7 Suppl 6():S13-9.
1995: Martin-Algarra S; Bishop M R; Tarantolo S; Cowles M K; Reed E; Anderson J R; Vose J M; Bierman P; Armitage J O; Kessinger A
Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
Experimental hematology 1995;23(14):1503-8.
1995: Haire W D; Ruby E I; Gordon B G; Patil K D; Stephens L C; Kotulak G D; Reed E C; Vose J M; Bierman P J; Kessinger A
Multiple organ dysfunction syndrome in bone marrow transplantation.
JAMA : the journal of the American Medical Association 1995;274(16):1289-95.
1995: Kessinger A; Bishop M R; Jackson J D; O'Kane-Murphy B; Vose J M; Bierman P J; Reed E C; Warkentin P I; Armitage J O; Sharp J G
Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignancies.
Experimental hematology 1995;23(7):609-12.
1995: Martin A R; Weisenburger D D; Chan W C; Ruby E I; Anderson J R; Vose J M; Bierman P J; Bast M A; Daley D T; Armitage J O
Prognostic value of cellular proliferation and histologic grade in follicular lymphoma.
Blood 1995;85(12):3671-8.
1995: Yan Y; Chan W C; Weisenburger D D; Anderson J R; Bast M A; Vose J M; Bierman P J; Armitage J O
Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(6):1336-42.
1995: Vaughan W P; Kris E; Vose J; Bierman P J; Gwilt P; Armitage J O
Phase I/II study incorporating intravenous hydroxyurea into high-dose chemotherapy for patients with primary refractory or relapsed and refractory intermediate-grade and high-grade malignant lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(5):1089-95.
1995: Kessinger A; Bishop M R; Anderson J R; Armitage J O; Bierman P J; Reed E C; Tarantolo S; Tempero M A; Vose J M; Warkentin P I
Comparison of subcutaneous and intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor for peripheral blood stem cell mobilization.
Journal of hematotherapy 1995;4(2):81-4.
1995: Vose J M
Chemotherapeutic palliative approaches in the treatment of lymphoma.
Seminars in oncology 1995;22(2 Suppl 3):53-7.
1995: Vose J M; Armitage J O
Clinical applications of hematopoietic growth factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(4):1023-35.
1995: Stewart D A; Vose J M; Weisenburger D D; Anderson J R; Ruby E I; Bast M A; Bierman P J; Kessinger A; Armitage J O
The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(3):263-6.
1995: Vose J M
Cytokine use in the older patient.
Seminars in oncology 1995;22(1 Suppl 1):6-8.
1995: Armitage J O; Bierman P J; Vose J M; Bishop M R; Kessinger M A
Autologous bone marrow transplantation for Hodgkin's disease.
Journal of hematotherapy 1995;4(1):61-2.
1995: Vose J M
CHLVPP therapy for Hodgkin's disease identification of prognostic factors.
Leukemia & lymphoma 1995;15 Suppl 1():13-4.
1994: Darrington D L; Vose J M; Anderson J R; Bierman P J; Bishop M R; Chan W C; Morris M E; Reed E C; Sanger W G; Tarantolo S R
Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(12):2527-34.
1994: Armitage J O; Vose J M; Bierman P J; Bishop M R
Salvage therapy for patients with lymphoma.
Seminars in oncology 1994;21(4 Suppl 7):82-5.
1994: Vose J M; Anderson J R; Bierman P J; Bast M; Weisenburger D; Chan W C; Bishop M R; Armitage J O
Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group.
Seminars in hematology 1994;31(2 Suppl 3):4-8.
1994: Bishop M R; Anderson J R; Jackson J D; Bierman P J; Reed E C; Vose J M; Armitage J O; Warkentin P I; Kessinger A
High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft.
Blood 1994;83(2):610-6.
1994: Kessinger A; Armitage J; Bierman P; Bishop M; Joshi S; Reed E; Sharp G; Talmadge J; Vose J
Clinical outcome of peripheral blood stem cell support.
Medical oncology (Northwood, London, England) 1994;11(2):43-6.
1994: Chan W C; Wu G Q; Greiner T C; Vose J M; Sharp J G
Detection of tumor contamination of peripheral stem cells in patients with lymphoma using cell culture and polymerase chain reaction technology.
Journal of hematotherapy 1994;3(3):175-84.
1993: Bierman P J; Bagin R G; Jagannath S; Vose J M; Spitzer G; Kessinger A; Dicke K A; Armitage J O
High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long-term follow-up in 128 patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(9):767-73.
1993: Vose J M; Anderson J R; Kessinger A; Bierman P J; Coccia P; Reed E C; Gordon B; Armitage J O
High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(10):1846-51.
1993: Vose J M; Armitage J O; Kessinger A
High-dose chemotherapy and autologous transplant with peripheral-blood stem cells.
Oncology (Williston Park, N.Y.) 1993;7(8):23-9; discussion 29-30, 33-4.
1993: Vose J M; Reed E C; Pippert G C; Anderson J R; Bierman P J; Kessinger A; Spinolo J; Armitage J O
Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(7):1306-10.
1993: Vose J M; Armitage J O
Role of autologous bone marrow transplantation in non-Hodgkin's lymphoma.
Hematology/oncology clinics of North America 1993;7(3):577-90.
1993: Nakamine H; Bagin R G; Vose J M; Bast M A; Bierman P J; Armitage J O; Weisenburger D D
Prognostic significance of clinical and pathologic features in diffuse large B-cell lymphoma.
Cancer 1993;71(10):3130-7.
1993: Bierman P J; Vose J M; Leichner P K; Quadri S M; Armitage J O; Klein J L; Abrams R A; Dicke K A; Vriesendorp H M
Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(4):698-703.
1993: Iwen P C; Reed E C; Armitage J O; Bierman P J; Kessinger A; Vose J M; Arneson M A; Winfield B A; Woods G L
Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1993;14(3):131-9.
1993: Anderson J R; Vose J M; Bierman P J; Weisenberger D D; Sanger W G; Pierson J; Bast M; Armitage J O
Clinical features and prognosis of follicular large-cell lymphoma: a report from the Nebraska Lymphoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(2):218-24.
1993: Gordon B G; Weisenburger D D; Warkentin P I; Anderson J; Sanger W G; Bast M; Gnarra D; Vose J M; Bierman P J; Armitage J O
Peripheral T-cell lymphoma in childhood and adolescence. A clinicopathologic study of 22 patients.
Cancer 1993;71(1):257-63.
1993: Vose J M; Armitage J O
What is the role of third generation regimens for initial therapy of non-Hodgkin's lymphomas?
Leukemia & lymphoma 1993;10 Suppl():61-4.
1993: Bishop M R; Bierman P J; Vose J M; Armitage J O
The role of high-dose therapy with hematopoietic stem cell rescue in low-grade non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4 Suppl 1():1-6.
1993: Kessinger A; Vose J M; Bierman P J; Bishop M; Armitage J O
Peripheral stem cell transplantation in non-Hodgkin's lymphoma patients.
Journal of hematotherapy 1993;2(3):361-2.
1992: Gordon B G; Warkentin P I; Weisenburger D D; Vose J M; Sanger W G; Strandjord S E; Anderson J R; Verdirame J D; Bierman P J; Armitage J O
Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents.
Blood 1992;80(11):2938-42.
1992: Vose J M; Bierman P J; Anderson J R; Kessinger A; Pierson J; Nelson J; Frappier B; Schmit-Pokorny K; Weisenburger D D; Armitage J O
Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up.
Blood 1992;80(8):2142-8.
1992: Braddock S W; Harrington D; Vose J
Generalized nodular cutaneous pseudolymphoma associated with phenytoin therapy. Use of T-cell receptor gene rearrangement in diagnosis and clinical review of cutaneous reactions to phenytoin.
Journal of the American Academy of Dermatology 1992;27(2 Pt 2):337-40.
1992: Sisson J H; Thompson A B; Anderson J R; Robbins R A; Spurzem J R; Spence P R; Reed E C; Armitage J O; Vose J M; Arneson M A
Airway inflammation predicts diffuse alveolar hemorrhage during bone marrow transplantation in patients with Hodgkin disease.
The American review of respiratory disease 1992;146(2):439-43.
1992: Vose J M; Kennedy B C; Bierman P J; Kessinger A; Armitage J O
Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies.
Cancer 1992;69(3):784-9.
1992: Masih A S; Weisenburger D D; Vose J M; Bast M A; Armitage J O
Histologic grade does not predict prognosis in optimally treated, advanced-stage nodular sclerosing Hodgkin's disease.
Cancer 1992;69(1):228-32.
1992: Letheby B; Jackson J; Greally J; Warkentin P; Smith D; Vose J; Bierman P; Kessinger A; Coccia P; Armitage J
Comparison of two methods of bone marrow processing for autologous bone marrow transplantation.
Progress in clinical and biological research 1992;377():345-51.
1991: Armitage J O; Bierman P J; Vose J M; Anderson J R; Weisenburger D D; Kessinger A; Reed E C; Vaughan W P; Coccia P F; Purtilo D T
Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease.
The American journal of medicine 1991;91(6):605-11.
1991: Bashir R M; Bierman P J; Vose J M; Weisenburger D D; Armitage J O
Central nervous system involvement in patients with diffuse aggressive non-Hodgkin's lymphoma.
American journal of clinical oncology 1991;14(6):478-82.
1991: Kessinger A; Vose J M; Bierman P J; Armitage J O
High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging.
Experimental hematology 1991;19(10):1013-6.
1991: Vose J M; Bierman P J; Weisenburger D D; Armitage J O
The therapy of non-Hodgkin's lymphomas. Introduction and overview.
Hematology/oncology clinics of North America 1991;5(5):845-52.
1991: Vose J M; Bierman P J; Anderson J R; Weisenburger D; Moravec D F; Sorensen S; Hutchins M; Dowling M D; Howe D; Okerbloom J
CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(8):1421-5.
1991: Kessinger A; Bierman P J; Vose J M; Armitage J O
High-dose cyclophosphamide, carmustine, and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease.
Blood 1991;77(11):2322-5.
1991: Vose J M; Armitage J O
The present status of therapy for patients with aggressive non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 2():171-6.
1991: Vose J M; Armitage J O
Diffuse "histiocytic" lymphoma.
Seminars in oncology 1991;18(1):50-60.
1991: Vose J M; Bierman P J; Kessinger A; Coccia P F; Anderson J; Oldham F B; Epstein C; Armitage J O
The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies.
Bone marrow transplantation 1991;7(2):139-43.
1990: Vose J M; Bierman P J; Armitage J O
Hodgkin's disease: the role of bone marrow transplantation.
Seminars in oncology 1990;17(6):749-57.
1990: Schouten H C; Maragos D; Vose J; Armitage J O
Diabetes mellitus or an impaired glucose tolerance as a potential complicating factor in patients treated with high-dose therapy and autologous bone marrow transplantation.
Bone marrow transplantation 1990;6(5):333-5.
1990: Vose J M; Peterson C; Bierman P J; Weisenburger D D; Linder J; Harrington D; Vaughan W P; Kessinger A; Armitage J O
Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas.
Blood 1990;76(2):424-31.
1989: Armitage J O; Vose J M; Linder J; Weisenburger D; Harrington D; Casey J; Bierman P; Sorensen S; Hutchins M; Moravec D F
Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(12):1783-90.
1989: Schouten H C; Bierman P J; Vaughan W P; Kessinger A; Vose J M; Weisenburger D D; Armitage J O
Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation.
Blood 1989;74(7):2579-84.
1989: Vose J M; Armitage J O; Bierman P J; Weisenburger D D; Hutchins M; Dowling M D; Moravec D F; Sorensen S; Okerbloom J; Bascom G
Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation.
The American journal of medicine 1989;87(3):285-8.
1988: Vose J M; Armitage J O; Weisenburger D D; Bierman P J; Sorensen S; Hutchins M; Moravec D F; Howe D; Dowling M D; Mailliard J
The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(12):1838-44.
1988: Vose J M; Armitage J O; Duggan M; Braddock S W
Pyoderma gangrenosum or cutaneous lymphoma: a difficult clinical diagnosis.
Cutis; cutaneous medicine for the practitioner 1988;42(4):335-7.
1988: Vose J; Armitage J; Weisenburger D; Moravec D; Hutchins M; Howe D; Sorensen S; Dowling M; Okerbloom J; Pevnick W
ChlVPP--an effective and well-tolerated alternative to MOPP therapy for Hodgkin's disease.
American journal of clinical oncology 1988;11(4):423-6.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Julie Vose

Research Profile (preview)

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Phenomena

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Julie Vose (preview)

All Publications